MDxHealth SA (NASDAQ:MDXH) Sees Significant Drop in Short Interest

MDxHealth SA (NASDAQ:MDXH - Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 15th, there was short interest totalling 13,300 shares, a decrease of 22.7% from the January 31st total of 17,200 shares. Currently, 0.1% of the company's shares are short sold. Based on an average daily volume of 121,000 shares, the days-to-cover ratio is presently 0.1 days.

MDxHealth Trading Down 6.9 %

Shares of MDxHealth stock traded down $0.11 on Friday, hitting $1.49. 184,901 shares of the company's stock traded hands, compared to its average volume of 87,222. The company has a fifty day moving average of $1.96 and a two-hundred day moving average of $2.16. MDxHealth has a one year low of $1.54 and a one year high of $3.85. The company has a market capitalization of $70.46 million, a price-to-earnings ratio of -0.98 and a beta of 1.37. The company has a debt-to-equity ratio of 3.14, a current ratio of 1.54 and a quick ratio of 1.45.

MDxHealth (NASDAQ:MDXH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.07. The firm had revenue of $24.74 million for the quarter, compared to analyst estimates of $22.67 million. MDxHealth had a negative return on equity of 1,077.84% and a negative net margin of 49.52%. As a group, sell-side analysts expect that MDxHealth will post -1.15 earnings per share for the current year.

Remove Ads

Analyst Ratings Changes

Separately, Piper Sandler reduced their price objective on shares of MDxHealth from $8.00 to $6.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th.

Institutional Investors Weigh In On MDxHealth

Large investors have recently bought and sold shares of the stock. AWM Investment Company Inc. raised its holdings in shares of MDxHealth by 11.1% during the fourth quarter. AWM Investment Company Inc. now owns 4,721,290 shares of the company's stock valued at $11,189,000 after purchasing an additional 471,290 shares during the period. Delta Investment Management LLC bought a new stake in MDxHealth in the 4th quarter valued at about $81,000. FAS Wealth Partners Inc. raised its stake in MDxHealth by 49.6% during the 4th quarter. FAS Wealth Partners Inc. now owns 24,425 shares of the company's stock worth $58,000 after buying an additional 8,100 shares during the period. Northern Trust Corp bought a new position in MDxHealth in the fourth quarter worth approximately $1,033,000. Finally, Northern Right Capital Management L.P. bought a new position in MDxHealth in the fourth quarter worth approximately $246,000.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.